AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Current Value
$13.041 Year Return
Current Value
$13.041 Year Return
Market Cap
$321.96M
P/E Ratio
-5.82
1Y Stock Return
27.43%
1Y Revenue Growth
32.24%
Dividend Yield
0.00%
Price to Book
27.8
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a company specializing in commercial-stage regenerative medicine and pioneering devices for wound care management and skin restoration, today announced it has entered into an exclusive distribution agreement with Revolution Surgical Pty Ltd. This agreement marks an important milestone in our expansion into the Australian and New Zealand markets. Under the terms of the agreement, Revolution Surgical
Yahoo
Shareholders of AVITA Medical, Inc. ( NASDAQ:RCEL ) will be pleased this week, given that the stock price is up 16% to...
SeekingAlpha
AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsJessica Ekeberg - Director, Investor...
Yahoo
VALENCIA, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on November 12, 2024, at 2:00 p.m. Pacific Standard Time (November 13, 2024, at 9:
SeekingAlpha
The following slide deck was published by AVITA Medical, Inc.
Yahoo
VALENCIA, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the third quarter ended September 30, 2024. Financial Results and Recent Business Updates Commercial revenue of $19.5 million, an increase of approximately 44% compared to the same period in 2023Gross profit margin of 83.7%On July 31,
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GL | 44.02% | $9.18B | -8.60% | 0.86% |
ACLX | 42.14% | $4.74B | +69.19% | 0.00% |
BLFS | 41.99% | $1.04B | +64.64% | 0.00% |
GDOT | 40.93% | $573.37M | +28.74% | 0.00% |
ATSG | 40.28% | $1.44B | +39.23% | 0.00% |
FOLD | 39.84% | $2.84B | -11.52% | 0.00% |
DDD | 39.83% | $402.06M | -35.13% | 0.00% |
CARG | 39.53% | $3.68B | +69.13% | 0.00% |
CLNE | 39.27% | $589.93M | -23.92% | 0.00% |
KOD | 38.89% | $296.80M | +150.67% | 0.00% |
G | 37.66% | $7.83B | +31.86% | 1.34% |
MRSN | 36.92% | $274.24M | +40.51% | 0.00% |
FRST | 36.18% | $302.36M | +21.93% | 3.29% |
CYRX | 35.95% | $342.80M | -48.82% | 0.00% |
LOVE | 35.73% | $513.90M | +78.25% | 0.00% |
AEO | 35.52% | $3.35B | +4.81% | 2.88% |
PRI | 35.24% | $9.94B | +42.36% | 1.02% |
ESTA | 35.22% | $968.33M | +54.98% | 0.00% |
LASR | 35.04% | $526.43M | -2.60% | 0.00% |
CSAN | 34.64% | $3.57B | -47.92% | 4.24% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LFVN | -0.03% | $169.84M | +130.61% | 1.10% |
ASPS | 0.18% | $22.36M | -80.26% | 0.00% |
TECX | 0.19% | $602.80M | +170.24% | 0.00% |
RILY | 0.35% | $145.72M | -79.86% | 20.75% |
QTTB | -0.38% | $354.34M | +188.64% | 0.00% |
ZTO | 0.41% | $12.58B | -4.71% | 4.73% |
TKO | 0.46% | $10.62B | +67.14% | 0.00% |
IMNN | 0.50% | $10.02M | -22.89% | 0.00% |
GAN | -0.52% | $83.39M | +21.19% | 0.00% |
GNK | 0.53% | $735.44M | +16.37% | 9.95% |
SPR | -0.55% | $3.72B | +23.27% | 0.00% |
CHRW | 0.58% | $12.89B | +32.52% | 2.24% |
MNOV | 0.63% | $93.19M | +2.15% | 0.00% |
CLX | 0.63% | $20.81B | +20.66% | 2.88% |
AVAL | -0.68% | $791.37M | -4.11% | 7.14% |
MX | 0.80% | $135.79M | -45.52% | 0.00% |
HE | 0.83% | $1.82B | -17.47% | 0.00% |
TXO | 0.87% | $737.26M | -1.80% | 13.22% |
MNR | -0.91% | $1.66B | -10.71% | 15.90% |
FENG | 0.92% | $13.37M | +96.77% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PCRX | -14.36% | $772.48M | -37.25% | 0.00% |
GOGL | -11.61% | $2.39B | +35.11% | 8.40% |
CYCN | -10.91% | $4.77M | -16.19% | 0.00% |
CBOE | -10.67% | $21.46B | +15.84% | 1.11% |
PULM | -10.56% | $19.83M | +202.98% | 0.00% |
NTIC | -9.74% | $132.27M | +24.98% | 2.02% |
PRPO | -9.63% | $9.10M | -13.65% | 0.00% |
LITB | -9.60% | $35.48M | -75.45% | 0.00% |
TCTM | -9.24% | $8.10M | -42.99% | 0.00% |
STG | -8.90% | $35.67M | +7.92% | 0.00% |
HUSA | -7.51% | $16.69M | -11.56% | 0.00% |
CME | -6.88% | $82.76B | +9.21% | 1.98% |
DOGZ | -6.56% | $614.77M | +1,372.26% | 0.00% |
NEUE | -5.36% | $40.93M | -34.13% | 0.00% |
MITK | -5.17% | $401.51M | -22.13% | 0.00% |
PEP | -4.62% | $215.02B | -6.60% | 3.35% |
CL | -4.22% | $76.48B | +22.25% | 2.12% |
PFE | -4.20% | $142.24B | -17.16% | 6.73% |
ACGL | -3.98% | $36.00B | +16.84% | 0.00% |
MCK | -3.93% | $78.15B | +35.51% | 0.42% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IWO | 49.05% | $12.56B | 0.24% |
IWC | 48.04% | $933.99M | 0.6% |
IWM | 47.90% | $75.73B | 0.19% |
VTWO | 47.73% | $12.38B | 0.1% |
PRFZ | 47.10% | $2.65B | 0.39% |
IJT | 46.87% | $6.64B | 0.18% |
SLYG | 46.83% | $3.69B | 0.15% |
NUSC | 46.63% | $1.27B | 0.31% |
VBK | 46.58% | $19.31B | 0.07% |
VB | 46.53% | $63.63B | 0.05% |
SMMD | 46.48% | $1.24B | 0.15% |
ISCG | 46.42% | $640.00M | 0.06% |
PSC | 46.40% | $702.17M | 0.38% |
ESML | 46.28% | $1.90B | 0.17% |
VIOO | 46.22% | $3.12B | 0.1% |
SPSM | 46.07% | $12.72B | 0.03% |
IJR | 45.99% | $90.05B | 0.06% |
GSSC | 45.96% | $529.86M | 0.2% |
EES | 45.74% | $668.71M | 0.38% |
RSPA | 45.73% | $273.87M | 0% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SOYB | 0.03% | $27.32M | 0.22% |
TBIL | 0.86% | $4.38B | 0.15% |
HIGH | -1.25% | $302.78M | 0.51% |
JBBB | 1.36% | $1.26B | 0.49% |
MINT | 1.53% | $11.62B | 0.35% |
BSCO | 1.97% | $2.35B | 0.1% |
GBIL | 1.97% | $5.60B | 0.12% |
SHV | 2.34% | $18.13B | 0.15% |
BOXX | 2.62% | $4.43B | 0.1949% |
CLOI | -2.79% | $715.40M | 0.4% |
TBLL | 2.84% | $1.92B | 0.08% |
YEAR | 2.99% | $1.13B | 0.25% |
XBIL | -3.16% | $637.70M | 0.15% |
HDRO | -3.34% | $164.26M | 0.3% |
DBMF | 3.36% | $1.02B | 0.85% |
ICLO | 3.88% | $209.30M | 0.2% |
EQLS | -4.08% | $76.08M | 1% |
DBA | 4.09% | $755.88M | 0.93% |
JUCY | 4.09% | $324.29M | 0.6% |
XHLF | 4.29% | $874.27M | 0.03% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -37.12% | $388.04M | 1.43% |
VIXY | -32.41% | $195.31M | 0.85% |
KRBN | -18.54% | $242.47M | 0.85% |
USDU | -17.20% | $201.97M | 0.5% |
TAIL | -16.95% | $67.98M | 0.59% |
UUP | -16.27% | $309.25M | 0.77% |
CTA | -13.68% | $350.27M | 0.78% |
WEAT | -9.67% | $120.27M | 0.28% |
CORN | -8.59% | $61.12M | 0.2% |
IBMM | -7.67% | $391.28M | 0.18% |
KMLM | -7.64% | $353.87M | 0.9% |
SGOV | -6.53% | $27.53B | 0.09% |
KCCA | -6.21% | $220.51M | 0.87% |
CSHI | -4.91% | $482.85M | 0.38% |
EQLS | -4.08% | $76.08M | 1% |
HDRO | -3.34% | $164.26M | 0.3% |
XBIL | -3.16% | $637.70M | 0.15% |
CLOI | -2.79% | $715.40M | 0.4% |
HIGH | -1.25% | $302.78M | 0.51% |
SOYB | 0.03% | $27.32M | 0.22% |